Prevalence of sarcopenia in patients with surgical obstructive jaundice and its impact on clinical outcomes

Table 8 Comparison between sarcopenia and non-sarcopenia patients with obstructive jaundice, mean ± SD/n (%)

Parameters	SC (n = 108)	Non-SC (n = 275)	t/χ2	P value
Age	70.44 ± 11.20	58.71 ± 12.42	-8.865	< 0.001
Sex			3.555
Male	62 (57.4)	186 (67.6)
Female	46 (42.6)	89 (32.4)
Malignant diseases	62 (57.4)	125 (45.5)	4.434	0.035
Nutritional risks	73 (67.6)	108 (39.3)	24.952	< 0.001
BMI	20.83 ± 2.72	25.11 ± 4.02	-9.712	< 0.001
PhA	4.27 ± 0.84	5.44 ± 1.07	-9.549	< 0.001
Hb	115.76 ± 20.69	127.69 ± 24.50	-4.588	< 0.001
LY	1.12 ± 0.57	1.25 ± 0.70	-1.520
Alb	34.85 ± 6.21	36.99 ± 6.36	-3.349	0.001
PNI	40.45 ± 7.14	43.24 ± 7.19	-3.700	< 0.001

BMI: Body mass index; PhA: Phase angle; Hb: Hemoglobin; LY: Lymphocyte count; Alb: Albumin; PNI: Prognostic nutritional index; SC: Sarcopenia.